gvtcx

Laboratory Validation for Hereditary Tyrosinemia 1 (HT1)

NHS england Published 23 Apr 2024 Contracts Finder

key details

Value£26,523
Statuscomplete
Category (CPV) 85111810
Deadline31 Dec 2023
Contract start1 Feb 2024
Contract end31 Jul 2024
Proceduredirect
SME suitableNo
OCIDocds-b5fd17-11dd918e-85f7-485e-8c89-0172acae95ca

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £26,523.

SupplierValueDateStatus
NHS GREATER GLASGOW AND CLYDE £26,523 25 Mar 2024 active
Synnovis LLP £28,245 25 Mar 2024 active

description

Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
23 Apr 2024 Award (award) · 67eb0867-a8e2-4069-b6d7-b69868a7fd20-743369
23 Apr 2024 Award (award) · 9ae7fb48-e837-40ec-b3d2-b67c32c6d407-743371

more from NHS england

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.